Lena (Olena) Mandrik, MSc Maastricht (the Netherlands), PhD Rotterdam (the Netherlands)

Research FellowOlena Mandrik

ScHARR, HEDS
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield
S1 4DA

Office: 1013

Tel: +44 (0) 114 222 6392

Email: o.mandrik@sheffield.ac.uk 

ORCiD: https://orcid.org/0000-0003-3755-3031

Biography

I joined ScHARR (HEDS) as a Research Fellow (modelling) in October 2018 after two-year post-doctoral fellowship in the International Agency for Research on Cancer of the World Health Organization (2016-2018). Prior to this I was employed by the Erasmus University Rotterdam, School of Health Policy and Management, were earlier (2015) I defended my PhD.

My path to science was long, and I have a seven-year experience in pharmaceutical business organizations. Starting from Manager in Pharmacoeconomics and growing to the Head of the Market Access Department, I was employed by such global companies as Janssen-Cilag, Merck, and Sanofi.

Research interests

• Implementation research (assessment of national programs);
• Global research, in particular for low- and middle-income countries;
• Cancer prevention and early detection (breast, colorectal cancers);
• Preferences of population and their consideration in cost-effectiveness models;
• Methods for assessment and synthesis of published economic evidence

Current projects

• I currently work on a microsimulation model for colorectal cancer

Key publications

1. Mandrik O, Ekwunife OI, Zielonke N, Meheus F, Severens JL, Lhachimi SK, Murillo R. What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews. Syst Rev. 2017 Jun 28;6(1):122. doi: 10.1186/s13643-017-0510-y.
2. Mandrik O, Corro Ramos I, Knies S, Al M, Severens JL. Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine. Cancer Manag Res. 2015 Aug 25;7:279-89.
3. Mandrik O, Knies S, Severens JL. Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan. Clinicoecon Outcomes Res. 2015 Jun 12;7:347-56.
4. Mandrik O, Knies S, Kalo Z, Severens JL. Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine. J Multidiscip Healthc. 2013 Jul 9;6:249-57.
5. Mandrik O, Severens JL, Doroshenko O, et al. Reviewing transferability in economic evaluations originating from eastern Europe. Int J Technol Assess Health Care. 2015;31(6):434-41

Journal articles

Conference proceedings papers